Health Care: Drugs

Biogen Inc (BIIB: NASDAQ)

$286.35 1.22 | 0.43%
02/27/17 - 12:16 PM ET
Company Income Statement
Dec 2016 Dec 2015 Dec 2014 Dec 2013
Sales 10.13B 9.42B 8.51B 5.81B
Cost of Sales 1.48B 1.02B 972.70M 668.90M
Gross Operating Profit 8.66B 8.40B 7.54B 5.14B
Selling, General, and Administrative Expenses 2.40B 2.11B 2.23B 1.80B
Research & Development 1.97B 2.01B 1.89B 1.44B
Operating Income before D & A (EBITDA) 4.28B 4.28B 3.41B 1.90B
Depreciation & Amortization 385.60M 600.40M 688.10M 531.70M
Interest Income n.a. 22.10M 12.20M 8.20M
Other Income - Net 1.10B 1.28B 1.19B 1.10B
Special Income / Charges -25.00M -30.50M 38.90M 25.40M
Total Income Before Interest Expenses (EBIT) 4.93B 4.85B 3.96B 2.50B
Interest Expense 0.00 95.50M 29.50M 31.90M
Pre-Tax Income 4.93B 4.75B 3.93B 2.46B
Income Taxes 1.24B 1.16B 989.90M 601.00M
Minority Interest -7.10M 46.20M 6.80M 0.00
Net Income From Continuing Operations 3.70B 3.59B 2.94B 1.86B
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations 3.70B 3.59B 2.94B 1.86B
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 -100.00K
Total Net Income 3.70B 3.55B 2.93B 1.86B
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
3.75B 3.72B 2.90B 1.84B
Preferred Dividends
Net Income Available To Common 0.00 3.59B 2.94B 1.86B
Basic EPS from Continuing Ops. 16.96 15.38 12.42 7.86
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations 16.96 15.38 12.42 7.86
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total 16.96 15.38 12.42 7.86
Basic Normalized Net Income/Share 17.23 15.91 12.26 7.75
EPS fr Continuing Ops. 16.93 15.34 12.37 7.81
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. 16.93 15.34 12.37 7.81
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total 16.93 15.34 12.37 7.81
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
17.20 15.87 12.21 7.70
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with BIIB

Latest BIIB Headlines from TheStreet

More Financial News for BIIB

Press Releases for BIIB

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter